QnAs with Eric S. Lander

摘要

This year marks the 10th anniver sary of the sequencing of the hu man genome. More than two decades after the launch of the Human Genome Project, researchers have made remarkable inroads into unraveling human biology, evolution, and disease. As the tools of genome sequencing and analysis grow more sophisticated, insights into the human genome will slowly shift the terrain in the treatment of disease. To be sure, the shift has already begun. Eric Lander, founding director of the Broad Institute of Harvard and Massachusetts Institute of Technology and a member of the National Academy of Sciences, offers PNAS readers his perspectives on the role of genome sequencing in the transfor mation of medicine.